The model effectively meets the criteria for Alzheimer’s disease (AD) formation, demonstrated by significant memory impairment, increased levels of brain lipid peroxidation biomarkers, elevated inflammatory cytokines, BACE1, and the presence of Aβ deposits. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.